Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2025 Earnings Call Transcript February 24, 2026
Iovance Biotherapeutics, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.22.
Operator: Good day, and thank you for standing by. Welcome to the Iovance Biotherapeutics Fourth quarter and Full Year 2025 Financial Results and Corporate Updates Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand...
